Abstract
In rare cases, generalized dystonia can rapidly progress to cause severe, continuous forceful contractions. This phenomenon—referred to as “dystonic storm” or “status dystonicus”—is a severe, life-threatening crisis that requires urgent evaluation and treatment. Dystonic storm can occur in idiopathic dystonia, or in symptomatic dystonia due to trauma, encephalitis, static encephalopathy, acute neuroleptic exposure, or neurodegenerative disorders. The differential diagnosis of dystonic storm includes bacterial meningitis, neuroleptic malignant syndrome, serotonin syndrome, malignant hyperthermia, and intrathecal baclofen withdrawal. Treatments for dystonic storm are empiric, and can be divided into three categories: supportive care, temporizing measures, and dystonia-specific treatments. Supportive care includes admission to an intensive care unit, mechanical ventilation, treatment with intravenous fluids and antipyretics, and monitoring of creatine phosphokinase, renal function, and urine output. Potential triggers (such as infection or medications) should also be identified and treated. Temporizing measures include the use of sedative-hypnotics, general anesthetics, or non-depolarizing paralytic agents. Dystonia-specific therapies should begin with catecholamine-depleting agents, anticholinergics, and/or dopamine receptor blocking agents. Other medications that may be effective include baclofen and benzodiazepines. If oral dystonia therapies are ineffective, then interventions such as an intrathecal baclofen pump or deep brain stimulation of the globus pallidus interna should be considered.
This chapter contains video segments that can be found on the accompanying DVD.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Fahn S. Concept and classification of dystonia. Adv Neurol. 1988;50:1–8.
Friedman J, Standaert DG. Dystonia and its disorders. Neurol Clin. 2001;19:681–705.
Jankovic J, Penn AS. Severe dystonia and myoglobinuria. Neurology. 1982;32:1195–7.
Marsden CD, Marion MH, Quinn N. The treatment of severe dystonia in children and adults. J Neurol Neurosurg Psychiatry. 1984;47:1166–73.
Manji H, Howard RS, Miller DH, et al. Status dystonicus: the syndrome and its management. Brain. 1998;121:243–52.
Svetel M, Sternic N, Pejovic S, Kostic VS. Penicillamine-induced lethal status dystonicus in a patient with Wilson’s disease. Mov Disord. 2001;16:568–9.
Opal P, Tintner R, Jankovic J, et al. Intrafamilial phenotypic variability of the DYT1 dystonia: from asymptomatic TOR1A gene carrier status to dystonic storm. Mov Disord. 2002;17:339–45.
Dalvi A, Fahn S, Ford B. Intrathecal baclofen in the treatment of dystonic storm. Mov Disord. 1998;13:611–2.
Vaamonde J, Narbona J, Weiser R, Garcia MA, Brannan T, Obeso JA. Dystonic storms: a practical management problem. Clin Neuropharmacol. 1994;17:344–7.
Paret G, Tirosh R, Ben-Zeev B, Vardi A, Brandt N, Barzilay Z. Rhabdomyolysis due to hereditary torsion dystonia. Pediatr Neurol. 1995;13:83–4.
Teive HA, Munhoz RP, Souza MM, et al. Status dystonicus: study of five cases. Arq Neuropsiquiatr. 2005;63:26–9.
Narayan RK, Loubser PG, Jankovic J, Donovan WH, Bontke CF. Intrathecal baclofen for intractable axial dystonia. Neurology. 1991;41:1141–2.
Samson-Fang L, Gooch J, Norlin C. Intrathecal baclofen withdrawal simulating neuroepileptic malignant syndrome in a child with cerebral palsy. Dev Med Child Neurol. 2000;42:561–5.
Watemberg N, Leshner RL, Armstrong BA, Lerman-Sagie T. Acute pediatric rhabdomyolysis. J Child Neurol. 2000;15:222–7.
Mariotti P, Fasano A, Contarino MF, et al. Management of status dystonicus: our experience and review of the literature. Mov Disord. 2007;22:963–8.
Ravi SD, Borge GF, Roach FL. Neuroleptics, laryngeal-pharyngeal dystonia and acute renal failure. J Clin Psychiatry. 1982;43:300.
Cavanaugh JJ, Finlayson RE. Rhabdomyolysis due to acute dystonic reaction to antipsychotic drugs. J Clin Psychiatry. 1984;45:356–7.
Delhaas EM, Brouwers JR. Intrathecal baclofen overdose: report of 7 events in 5 patients and review of the literature. Int J Clin Pharmacol Ther Toxicol. 1991;29:274–80.
Grandas F, Fernandez-Carballal C, Guzman-de-Villoria J, Ampuero I. Treatment of a dystonic storm with pallidal stimulation in a patient with PANK2 mutation. Mov Disord. 2011;26(5):921–2.
Elkay M, Silver K, Penn RD, Dalvi A. Dystonic storm due to Batten’s disease treated with pallidotomy and deep brain stimulation. Mov Disord. 2009;24:1048–53.
Apetauerova D, Schirmer CM, Shils JL, Zani J, Arle JE. Successful bilateral deep brain stimulation of the globus pallidus internus for persistent status dystonicus and generalized chorea. J Neurosurg. 2010;113:634–8.
Paliwal VK, Gupta PK, Pradhan S. Gabapentin as a rescue drug in D-penicillamine-induced status dystonicus in patients with Wilson disease. Neurol India. 2010;58:761–3.
Mishra D, Singhal S, Juneja M. Status dystonicus a rare complication of dystonia. Indian Pediatr. 2010;47:883–5.
Ford B, Greene P, Louis ED, et al. Use of intrathecal baclofen in the treatment of patients with dystonia. Arch Neurol. 1996;53:1241–6.
Muirhead W, Jalloh I, Vloeberghs M. Status dystonicus resembling the intrathecal baclofen withdrawal syndrome: a case report and review of the literature. J Med Case Reports. 2010;4:294.
Teddy P, Jamous A, Gardner B, Wang D, Silver J. Complications of intrathecal baclofen delivery. Br J Neurosurg. 1992;6:115–8.
Fahn S. High dosage anticholinergic therapy in dystonia. Neurology. 1983;33:1255–61.
Penn RD. Intrathecal baclofen for spasticity of spinal origin: seven years of experience. J Neurosurg. 1992;77:236–40.
Kravitz HM, Corcos DM, Hansen G, Penn RD, Cartwright RD, Gianino J. Intrathecal baclofen: effects on nocturnal leg muscle spasticity. Am J Phys Med Rehabil. 1992;71:48–52.
Ford B, Greene PE, Louis ED, et al. Intrathecal baclofen in the treatment of dystonia. Adv Neurol. 1998;78:199–210.
Hou JG, Ondo W, Jankovic J. Intrathecal baclofen for dystonia. Mov Disord. 2001;16:1201–2.
Albright AL, Barry MJ, Shafton DH, Ferson SS. Intrathecal baclofen for generalized dystonia. Dev Med Child Neurol. 2001;43:652–7.
Walker RH, Danisi FO, Swope DM, Goodman RR, Germano IM, Brin MF. Intrathecal baclofen for dystonia: benefits and complications during six years of experience. Mov Disord. 2000;15:1242–7.
Silbert PL, Stewart-Wynne EG. Increased dystonia after intrathecal baclofen. Neurology. 1992;42:1639–40.
Kyriagis M, Grattan-Smith P, Scheinberg A, Teo C, Nakaji N, Waugh M. Status dystonicus and Hallervorden-Spatz disease: treatment with intrathecal baclofen and pallidotomy. J Paediatr Child Health. 2004;40:322–5.
Jaffe MS, Nienstedt LJ. Intrathecal baclofen for generalized dystonia: a case report. Arch Phys Med Rehabil. 2001;82:853–5.
Penn RD, Gianino JM, York MM. Intrathecal baclofen for motor disorders. Mov Disord. 1995;10:675–7.
Siegfried RN, Jacobson L, Chabal C. Development of an acute withdrawal syndrome following the cessation of intrathecal baclofen in a patient with spasticity. Anesthesiology. 1992;77:1048–50.
Kupsch A, Kuehn A, Klaffke S, et al. Deep brain stimulation in dystonia. J Neurol. 2003;250 Suppl 1:I47–52.
Yianni J, Bain PG, Gregory RP, et al. Post-operative progress of dystonia patients following globus pallidus internus deep brain stimulation. Eur J Neurol. 2003;10:239–47.
Krauss JK, Loher TJ, Weigel R, Capelle HH, Weber S, Burgunder JM. Chronic stimulation of the globus pallidus internus for treatment of non-DYT1 generalized dystonia and choreoathetosis: 2-year follow up. J Neurosurg. 2003;98:785–92.
Yianni J, Bain P, Giladi N, et al. Globus pallidus internus deep brain stimulation for dystonic conditions: a prospective audit. Mov Disord. 2003;18:436–42.
Krauss JK. Deep brain stimulation for dystonia in adults: overview and developments. Stereotact Funct Neurosurg. 2002;78:168–82.
Vercueil L, Pollak P, Fraix V, et al. Deep brain stimulation in the treatment of severe dystonia. J Neurol. 2001;248:695–700.
Krack P, Vercueil L. Review of the functional surgical treatment of dystonia. Eur J Neurol. 2001;8:389–99.
Ondo WG, Desaloms JM, Jankovic J, Grossman RG. Pallidotomy for generalized dystonia. Mov Disord. 1998;13:693–8.
Balas I, Kovacs N, Hollody K. Staged bilateral stereotactic pallidothalamotomy for life-threatening dystonia in a child with Hallervorden-Spatz disease. Mov Disord. 2006;21:82–5.
Jech R, Bares M, Urgosik D, et al. Deep brain stimulation in acute management of status dystonicus. Mov Disord. 2009;24:2291–2.
Zorzi G, Marras C, Nardocci N, et al. Stimulation of the globus pallidus internus for childhood-onset dystonia. Mov Disord. 2005;20:1194–200.
Beric A, Kelly PJ, Rezai A, et al. Complications of deep brain stimulation surgery. Stereotact Funct Neurosurg. 2001;77:73–8.
Lozano AM, Kumar R, Gross RE, et al. Globus pallidus internus pallidotomy for generalized dystonia. Mov Disord. 1997;12:865–70.
Abosch A, Lozano A. Stereotactic neurosurgery for movement disorders. Can J Neurol Sci. 2003;30 Suppl 1:S72–82.
Hariz MI, De Salles AA. The side-effects and complications of posteroventral pallidotomy. Acta Neurochir Suppl. 1997;68:42–8.
Hariz MI. Complications of deep brain stimulation surgery. Mov Disord. 2002;17 Suppl 3:S162–6.
Angelini L, Nardocci N, Estienne M, Conti C, Dones I, Broggi G. Life-threatening dystonia-dyskinesias in a child: successful treatment with bilateral pallidal stimulation. Mov Disord. 2000;15:1010–2.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Electronic Supplementary Material
Movement_Disorders_Emergencies_C9.mov (110,800 KB)
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this chapter
Cite this chapter
Nirenberg, M.J., Ford, B. (2013). Dystonic Storm. In: Frucht, S. (eds) Movement Disorder Emergencies. Current Clinical Neurology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60761-835-5_9
Download citation
DOI: https://doi.org/10.1007/978-1-60761-835-5_9
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-60761-834-8
Online ISBN: 978-1-60761-835-5
eBook Packages: MedicineMedicine (R0)